1. Home
  2. PLUR vs ZGM Comparison

PLUR vs ZGM Comparison

Compare PLUR & ZGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUR
  • ZGM
  • Stock Information
  • Founded
  • PLUR 2001
  • ZGM 2019
  • Country
  • PLUR Israel
  • ZGM Macau
  • Employees
  • PLUR N/A
  • ZGM N/A
  • Industry
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • ZGM Professional Services
  • Sector
  • PLUR Health Care
  • ZGM Consumer Discretionary
  • Exchange
  • PLUR Nasdaq
  • ZGM Nasdaq
  • Market Cap
  • PLUR 36.9M
  • ZGM 32.6M
  • IPO Year
  • PLUR N/A
  • ZGM 2025
  • Fundamental
  • Price
  • PLUR $3.95
  • ZGM $2.08
  • Analyst Decision
  • PLUR Strong Buy
  • ZGM
  • Analyst Count
  • PLUR 1
  • ZGM 0
  • Target Price
  • PLUR $12.00
  • ZGM N/A
  • AVG Volume (30 Days)
  • PLUR 52.1K
  • ZGM 64.5K
  • Earning Date
  • PLUR 11-12-2025
  • ZGM 01-06-2026
  • Dividend Yield
  • PLUR N/A
  • ZGM N/A
  • EPS Growth
  • PLUR N/A
  • ZGM 401.52
  • EPS
  • PLUR N/A
  • ZGM 0.17
  • Revenue
  • PLUR $1,326,000.00
  • ZGM $3,620,780.00
  • Revenue This Year
  • PLUR $97.38
  • ZGM N/A
  • Revenue Next Year
  • PLUR $293.97
  • ZGM N/A
  • P/E Ratio
  • PLUR N/A
  • ZGM $11.78
  • Revenue Growth
  • PLUR 121.74
  • ZGM 211.78
  • 52 Week Low
  • PLUR $3.22
  • ZGM $1.90
  • 52 Week High
  • PLUR $7.13
  • ZGM $4.51
  • Technical
  • Relative Strength Index (RSI)
  • PLUR 48.02
  • ZGM N/A
  • Support Level
  • PLUR $3.50
  • ZGM N/A
  • Resistance Level
  • PLUR $4.12
  • ZGM N/A
  • Average True Range (ATR)
  • PLUR 0.37
  • ZGM 0.00
  • MACD
  • PLUR 0.03
  • ZGM 0.00
  • Stochastic Oscillator
  • PLUR 36.83
  • ZGM 0.00

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About ZGM Zenta Group Company Limited Ordinary Shares

Zenta Group Co Ltd is engaged in the provision of industrial park consultation services, business investment consultation services to clients through LIC, and sales of fintech products and services through LFT. Its industrial park consultation services are focused on the pre-development stage. Its business investment consultation services, offered through LIC, mainly focus on assisting clients to acquire stakes in specific investments, and it's normally in the form of equity ownership.

Share on Social Networks: